Paratek Pharmaceuticals, Inc. (PRTK) Social Stream
Paratek Pharmaceuticals Inc (PRTK) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Paratek Pharmaceuticals Inc.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 4 | $34 | $10 | $21.75 | $4.77 | 355.97% |
The Trend in the Analyst Price Target
Over the past 64 days, PRTK's average price target has gone up $2.15.
Over the past 17 months, PRTK's average upside potential has been 200.86%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-09-19 | 4 | 34 | 10 | 21.75 | 4.80 | 353.12% |
| 2021-09-18 | 4 | 34 | 10 | 21.75 | 4.80 | 353.12% |
| 2021-09-11 | 4 | 34 | 10 | 21.75 | 4.97 | 337.63% |
| 2021-09-04 | 4 | 34 | 10 | 21.75 | 5.34 | 307.3% |
| 2021-08-28 | 4 | 34 | 10 | 21.75 | 5.53 | 293.31% |
| 2021-08-14 | 5 | 34 | 10 | 19.60 | 5.61 | 249.38% |
| 2021-08-07 | 5 | 34 | 10 | 19.60 | 5.78 | 239.1% |
| 2021-08-05 | 5 | 34 | 10 | 19.60 | 5.58 | 251.25% |
| 2021-08-01 | 5 | 34 | 10 | 19.60 | 5.20 | 276.92% |
| 2021-07-24 | 5 | 34 | 10 | 19.60 | 5.48 | 257.66% |
| 2021-07-17 | 5 | 34 | 10 | 19.60 | 5.91 | 231.64% |
| 2021-07-10 | 5 | 34 | 10 | 19.60 | 6.68 | 193.41% |
| 2021-07-03 | 5 | 34 | 10 | 19.60 | 6.94 | 182.42% |
| 2021-06-26 | 5 | 34 | 10 | 19.60 | 7.01 | 179.6% |
| 2021-06-13 | 5 | 34 | 10 | 18.40 | 10.72 | 71.64% |
| 2021-06-05 | 5 | 34 | 10 | 18.40 | 9.60 | 91.67% |
| 2021-05-22 | 5 | 34 | 10 | 18.40 | 8.08 | 127.72% |
| 2021-05-15 | 5 | 34 | 10 | 18.40 | 7.60 | 142.11% |
| 2021-05-08 | 5 | 34 | 10 | 18.40 | 7.34 | 150.68% |
| 2021-04-25 | 5 | 34 | 10 | 18.40 | 7.78 | 136.5% |
| 2021-04-17 | 4 | 34 | 11 | 20.50 | 8.01 | 155.93% |
| 2021-04-10 | 4 | 34 | 11 | 20.50 | 7.96 | 157.54% |
| 2021-04-03 | 4 | 34 | 11 | 20.50 | 7.03 | 191.61% |
| 2021-03-20 | 4 | 34 | 11 | 20.50 | 7.90 | 159.49% |
| 2021-03-13 | 5 | 34 | 11 | 19.20 | 7.83 | 145.21% |
| 2021-03-06 | 5 | 34 | 11 | 19.20 | 7.10 | 170.42% |
| 2021-02-27 | 4 | 34 | 11 | 20.25 | 7.48 | 170.72% |
| 2021-02-20 | 4 | 34 | 11 | 20.25 | 7.55 | 168.21% |
| 2021-02-13 | 4 | 34 | 11 | 20.25 | 7.82 | 158.95% |
| 2021-02-06 | 4 | 34 | 11 | 20.25 | 7.86 | 157.63% |
| 2021-01-30 | 4 | 34 | 11 | 20.25 | 6.49 | 212.02% |
| 2021-01-23 | 4 | 34 | 11 | 20.25 | 6.66 | 204.05% |
| 2021-01-16 | 5 | 34 | 6 | 17.40 | 6.80 | 155.88% |
| 2021-01-09 | 5 | 34 | 6 | 17.40 | 6.31 | 175.75% |
| 2021-01-02 | 5 | 34 | 6 | 17.40 | 6.26 | 177.96% |
| 2020-12-26 | 5 | 34 | 6 | 17.40 | 6.62 | 162.84% |
| 2020-12-19 | 5 | 34 | 6 | 17.40 | 6.51 | 167.28% |
| 2020-12-09 | 5 | 34 | 6 | 17.40 | 6.94 | 150.72% |
| 2020-12-07 | 5 | 34 | 6 | 17.40 | 6.89 | 152.54% |
| 2020-11-06 | 4 | 34 | 11 | 20.25 | 5.61 | 260.96% |
| 2020-10-24 | 4 | 34 | 11 | 19.50 | 4.95 | 293.94% |
| 2020-09-30 | 4 | 34 | 11 | 19.50 | 5.41 | 260.44% |
| 2020-08-10 | 5 | 34 | 6 | 16.80 | NA | NA% |
| 2020-05-11 | 5 | 34 | 6 | 16.80 | NA | NA% |
PRTK Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.25 | 2 | 2 | 0 | 0 | 0 | 4 |
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for PRTK as an investment opportunity.
- The variance in analysts' estimates of PRTK is less than 3.58% of all US stocks.
- PRTK has a greater upside potential (average analyst target price relative to current price) than 95.47% of all US stocks.
- PRTK has a greater number of analysts covering the stock than 33.99% of Pharmaceutical Products stocks.
- PRTK has a greater average analyst price target than 39.55% of all US stocks.
In the Pharmaceutical Products industry, EPIX, AGRX and ONCY are the three stocks most similar to Paratek Pharmaceuticals Inc regarding the price target and analyst recommendation information presented here.
Make investment decisions regarding PRTK using the data that counts. Try POWR Ratings for free.